Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Photonic nanoparticles: emerging theranostics in cancer treatment.
Shahcheraghi SH, Shahcheraghi SH, Lotfi M, Lotfi M, Khaleghinejad SH, Tambuwala ZM, Mishra V, Mishra Y, Serrano-Aroca Á, A Aljabali AA, El-Tanani M, Naikoo GA, Chava SR, Charbe NB, Bharti S, Jaganathan SK, Goyal R, Negi P, Tambuwala MM, Folorunso O. Shahcheraghi SH, et al. Among authors: lotfi m. Ther Deliv. 2023 Apr;14(4):311-329. doi: 10.4155/tde-2023-0011. Epub 2023 Jul 5. Ther Deliv. 2023. PMID: 37403985 Review.
An overview of vaccine development for COVID-19.
Shahcheraghi SH, Ayatollahi J, Aljabali AA, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Katari NK, Mehta M, Satija S, Dureja H, Mishra V, Almutary AG, Alnuqaydan AM, Charbe N, Prasher P, Gupta G, Dua K, Lotfi M, Bakshi HA, Tambuwala MM. Shahcheraghi SH, et al. Among authors: lotfi m. Ther Deliv. 2021 Mar;12(3):235-244. doi: 10.4155/tde-2020-0129. Epub 2021 Feb 24. Ther Deliv. 2021. PMID: 33624533 Free PMC article. Review.
Overview of key molecular and pharmacological targets for diabetes and associated diseases.
Shahcheraghi SH, Aljabali AAA, Al Zoubi MS, Mishra V, Charbe NB, Haggag YA, Shrivastava G, Almutary AG, Alnuqaydan AM, Barh D, Dua K, Chellappan DK, Gupta G, Lotfi M, Serrano-Aroca Á, Bahar B, Mishra YK, Takayama K, Panda PK, Bakshi HA, Tambuwala MM. Shahcheraghi SH, et al. Among authors: lotfi m. Life Sci. 2021 Aug 1;278:119632. doi: 10.1016/j.lfs.2021.119632. Epub 2021 May 18. Life Sci. 2021. PMID: 34019900 Review.
Targeting LIN28: a new hope in prostate cancer theranostics.
Shrivastava G, Aljabali AA, Shahcheraghi SH, Lotfi M, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Dureja H, Pabari RM, Mishra V, Almutary AG, Alnuqaydan AM, Charbe N, Prasher P, Negi P, Goyal R, Dua K, Gupta G, Serrano-Aroca Á, Bahar B, Barh D, Panda PK, Takayama K, Lundstorm K, McCarron P, Bakshi H, Tambuwala MM. Shrivastava G, et al. Among authors: lotfi m. Future Oncol. 2021 Oct;17(29):3873-3880. doi: 10.2217/fon-2021-0247. Epub 2021 Jul 15. Future Oncol. 2021. PMID: 34263659 Review.
Gene Therapy for Neuropsychiatric Disorders: Potential Targets and Tools.
Shahcheraghi SH, Ayatollahi J, Lotfi M, Aljabali AAA, Al-Zoubi MS, Panda PK, Mishra V, Satija S, Charbe NB, Serrano-Aroca Á, Bahar B, Takayama K, Goyal R, Bhatia A, Almutary AG, Alnuqaydan AM, Mishra Y, Negi P, Courtney A, McCarron PA, Bakshi HA, Tambuwala MM. Shahcheraghi SH, et al. Among authors: lotfi m. CNS Neurol Disord Drug Targets. 2023;22(1):51-65. doi: 10.2174/1871527321666220304153719. CNS Neurol Disord Drug Targets. 2023. PMID: 35249508 Review.
490 results